At a time of skyrocketing prescription drug costs, Michigan families need a Health Secretary who will take on big Pharma. That’s not Alex Azar. As a top executive at Eli Lily, Mr. Azar oversaw incredible price increases for prescription drugs. That includes a 345% increase in the cost of insulin, an essential drug for millions of Americans suffering from diabetes.
President Trump’s decision to nominate Azar shows he isn’t taking his promise to lower drug costs for Michigan families seriously. I will be opposing Mr. Azar’s nomination and I urge my colleagues to do the same.